A study published in the journal Frontiers of Medicine has found an association between the inactivated COVID-19 vaccine CoronaVac from Sinovac Biotech and immune thrombotic thrombocytopenic purpura ...

The COVID-19 pandemic has prompted the rapid development and administration of various vaccines worldwide, with some reports linking these vaccines to immune thrombotic thrombocytopenic purpura (TTP).

This report presents two cases of TTP occurring after the administration of the inactivated vaccine CoronaVac from Sinovac ...

The first case details a 23-year-old female who developed symptoms of TTP three days after receiving her second dose of CoronaVac. Initially presenting with dizziness and weakness, her condition ...

The COVID-19 pandemic has prompted the rapid development and administration of various vaccines worldwide, with some reports ...

According to a study released Tuesday by Brazil's Oswaldo Cruz Foundation (Fiocruz), patients who have taken the two-shot scheme of CoronaVac's drug would be better off if they receive a booster ...

Antibody proteomics advances vaccine research, revealing immune responses and identifying proteins essential for developing effective vaccines against diseases.

Abstract The present study aimed to evaluate the effectiveness of two doses of CoronaVac in preventing SARS-CoV-2 symptomatic disease with virological confirmation, as well as in the prevention of ...